Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Cancer treatment A small 2018 study suggests certain cancer treatments, such as chemotherapy , may cause L-carnitine deficiencies
Tirzepatide's dual agonism of GIP and GLP-1 receptors allows for enhanced glycemic control and appetite regulation
Further, while studies are still ongoing, GLP-1 products are also thought to have benefits for sleep apnea, cardiovascular events (like heart attack and stroke), Type 1 Diabetes, and more
Retatrutide is a novel synthetic peptide that functions as a triple receptor agonist, acting on the GLP-1, GIP, and glucagon receptors
US$ 26.43
US$ 21.22
US$ 25.81
US$ 29.63
US$ 26.15
